At a location that has been manufacturing pharmaceuticals for over 90 years in Helsingborg in the south of Sweden, McNeil AB specializes in the manufacture of over-the-counter healthcare products. It is the only plant producing the world leading Nicorette family of nicotine replacement therapy products.
Introduced in 1978, Nicorette gum provides the user with a source of pure nicotine while avoiding the harmful effects of tobacco smoke. By 2005, around 18 billion pieces of gum had been produced. Current production at Helsingborg is on a 24/7 basis of between 2 and 3 billion pieces per year, exported to around 80 countries worldwide.
Research and development takes place at the Helsingborg plant. In order to satisfy differing consumer demands, Nicorette has been developed into different formats which are also produced there. As examples, Nicorette Patch entered the market in 1991 to provide a continuous nicotine supply throughout the day; 1994 saw the introduction of Nicorette Nasal Spray for quick absorption of a nicotine dose; a Nicorette Inhaler was developed in 1996 which satisfies some users’ demand to have their hands occupied; in 1998 Nicorette Microtab with a slow release profile for placement under the tongue was put on the market, and in 2004 a crisp coated, sweeter and softer mint gum was added to the Nicorette family, Nicorette Freshmint Gum.
"We have been able to develop a customised solution, paying only for the elements we need."
Annette Cederhag, Project manager Engineering Maintenance Utility, McNeil